Drug news
CE Mark granted for ER-REBOA emergency occlusion balloon catheter in support of hemorrhage control.-Prytime Medical Devices.
Prytime Medical Devices, a company based outside of San Antonio, Texas formerly known as Pryor Medical Devices,has won CE Mark clearance to introduce its ER-REBOA emergency occlusion balloon catheter in Europe. Designed to occlude large vessels, the aorta in particular, it provides time for doctors to stabilize a patient before too much blood loss occurs.
In October 2015 the FDA granted 510(k) approval for the device to temporarily occlude large vessels using a balloon in support of hemorrhage control.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
3 mins